Smartlens, Inc.
Overview
Smartlens, Inc. develops technologies for continuous monitoring, diagnosis, and treatment optimization of anterior segment diseases, focusing on intraocular pressure management for glaucoma through devices like the miLens and AI-powered platforms.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Smartlens, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.